LinkedIn Reinstates Account of mRNA Vaccine Inventor Who Questions COVID-19 Vaccine Benefit for Children

LinkedIn Reinstates Account of mRNA Vaccine Inventor Who Questions COVID-19 Vaccine Benefit for Children
Dr. Robert Malone, who invented mRNA vaccine technology, in Washington, on June 29, 2021. (Zhen Wang/The Epoch Times)

LinkedIn has reinstated the account of mRNA vaccine technology inventor Dr. Robert Malone, who said his page was deleted last week after he made comments about mRNA COVID-19 vaccines and questioned whether they’re appropriate to give to certain groups of people.

In a Twitter post on Monday evening, Malone said he’d received a “very kind and personal note from a senior executive of LinkedIn,” and shared, with permission, an anonymized version of the message.

“Dr. Malone’s account has been fixed as of this morning,” the note from the LinkedIn official read. “I’d like to apologize on behalf of LinkedIn—we’re just not good enough at detangling complicated, subtle scientific claims concurrent with similar (but different) misinformation coming from others.”

Malone said he is “truly grateful for his kind gesture.”

Last week, Malone wrote on Twitter that his business pays for LinkedIn Premium and that he had been “deleted.”

In a subsequent tweet, Malone produced an email (pdf) from a LinkedIn representative, who said that his account violated the firm’s user agreement because he posted “misleading or inaccurate information” about vaccines and COVID-19.

“[LinkedIn] has provided a list of my thoughtcrimes. An amazing document,” Malone wrote at the time.

Meanwhile his wife, Jill Malone, told Just the News that his personal account was removed without warning or explanation from LinkedIn, a subsidiary of Microsoft.

Recently, Malone’s claims to Fox News and other news outlets about giving vaccines to individuals under the age of 18 were flagged by several self-claimed “fact-checking” sites. Malone told EpochTV’s “The Nation Speaks” in late June that heart inflammation reports shift the risk-benefit ratio for children.

“Vaccines save lives. These vaccines have saved lives,” Malone said. But he warned that he believes the risks associated with the COVID-19 vaccines made by Pfizer and Moderna due to use of the spike protein outweigh the benefits for children.

Speaking to Fox News, Malone said, “I can say that the risk-benefit ratio for those 18 and below doesn’t justify vaccines, and there’s a pretty good chance that it doesn’t justify vaccination in these very young adults.”

Shortly after Malone’s LinkedIn account was reinstated, he took to the platform to say that he will be “migrating off of this platform now,” adding that it is “not powered for actual scientific discussion.”

He directed others to follow updates from him on his Twitter account, where he posts “new links” and podcasts.

NTD Photo
In this photo illustration, the LinkedIn app is seen on a mobile phone in London, England, on Jan. 11, 2021. (Edward Smith/Getty Images)

Just hours after that post, Malone said he has been “warned via second hand information” that he will be deleted from LinkedIn again “at a moments notice if I again transgress.”

“So please forgive me if my discussions here now become quite superficial,” Malone said. “I will be migrating to the blog on my personal website and to trial site news. You may be interested in setting up an account at trial site. I will keep any interested apprised of further developments as they mature.”

The Epoch Times has reached out to LinkedIn for comment.

LinkedIn’s move to ban Malone is the latest example of attempts by Big Tech firms to manage reports of “misinformation” on their platforms. Recently, Twitter locked Harvard Medical School epidemiologist Martin Kulldorff’s account after he expressed a skeptical viewpoint on whether common surgical masks actually provide protection from COVID-19.

Jack Phillips contributed to this report.

From The Epoch Times

ntd newsletter icon
Sign up for NTD Daily
What you need to know, summarized in one email.
Stay informed with accurate news you can trust.
By registering for the newsletter, you agree to the Privacy Policy.